Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Campone, Mario"'
Autor:
Nocquet L; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France., Roul J; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France.; ICO René Gauducheau, Saint Herblain, France., Lefebvre CC; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France., Duarte L; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France., Campone M; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; SIRIC ILIAD, Nantes, Angers, France.; ICO René Gauducheau, Saint Herblain, France., Juin PP; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France. philippe.juin@univ-nantes.fr.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France. philippe.juin@univ-nantes.fr.; SIRIC ILIAD, Nantes, Angers, France. philippe.juin@univ-nantes.fr.; ICO René Gauducheau, Saint Herblain, France. philippe.juin@univ-nantes.fr., Souazé F; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France. frederique.souaze@univ-nantes.fr.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France. frederique.souaze@univ-nantes.fr.; SIRIC ILIAD, Nantes, Angers, France. frederique.souaze@univ-nantes.fr.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 19; Vol. 14 (1), pp. 14177. Date of Electronic Publication: 2024 Jun 19.
Autor:
Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors, 08036 Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain; Department of Medicine, University of Barcelona, 08036 Barcelona, Spain. Electronic address: schettini@clinic.cat., Venturini S; Department of Economic and Social Sciences, Catholic University of Sacred Heart - Cremona Campus, 26100 Cremona, Italy. Electronic address: sergio.venturini@unicatt.it., Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy. Electronic address: m.giuliano@unina.it., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, 16132 Genova, Italy; Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy. Electronic address: matteo.lambertini@unige.it., Pinato DJ; Division of Cancer, Department of Surgery and Cancer, Imperial College London, SW7 2AZ London, UK; Department of Translational Medicine, Università del Piemonte Orientale 'A. Avogadro', 28100 Novara, Italy. Electronic address: david.pinato@imperial.ac.uk., Onesti CE; Clinical and Oncological Research Department, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy., De Placido P; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy., Harbeck N; Breast Center, Department OB&GYN and CCCLMU, LMU University Hospital, 81377 Munich, Germany. Electronic address: nadia.harbeck@med.uni-muenchen.de., Lüftner D; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany. Electronic address: diana.lueftner@charite.de., Denys H; Department of Medical Oncology, UZ Gent, 9000 Gent, Belgium. Electronic address: hannelore.denys@ugent.be., Van Dam P; Oncology Department, University Hospital Antwerp (UZA), 2650 Edegem, Belgium. Electronic address: peter.vandam@uza.be., Arpino G; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy. Electronic address: grazia.arpino@unina.it., Zaman K; Oncology Department, Lausanne University Hospital CHUV, 1011 Lausanne, Switzerland. Electronic address: khalil.zaman@chuv.ch., Mustacchi G; Medical Oncology, University of Trieste, 34127 Trieste, Italy. Electronic address: mail@mustacchioncology.it., Gligorov J; Department of Medical Oncology, Tenon Hospital, Institut Universitaire de Cancérologie AP-HP, Sorbonne University, 75004 Paris, France. Electronic address: joseph.gligorov@tnn.aphp.fr., Awada A; Oncology Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium. Electronic address: ahmad.awada@bordet.be., Campone M; Medical Oncology, Institut de Cancérologie de l'Ouest-Pays de la Loire, 44800 Saint-Herblain, France. Electronic address: mario.campone@ico.unicancer.fr., Wildiers H; Department of General Medical Oncology, University Hospital Leuven, 3000 Leuven, Belgium. Electronic address: hans.wildiers@uzleuven.be., Gennari A; Department of Translational Medicine, Università del Piemonte Orientale 'A. Avogadro', 28100 Novara, Italy. Electronic address: alessandra.gennari@uniupo.it., Tjan-Heijnen V; Medical Oncology, Maastricht University Medical Center (MUMC), 6229 HX Maastricht, Netherlands. Electronic address: vcg.tjan.heijnen@mumc.nl., Bartsch R; Division of Oncology, Department of Medicine 1, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: rupert.bartsch@meduniwien.ac.at., Cortes J; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA; Vall d́Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. Electronic address: jacortes@vhio.net., Paris I; Department of Woman and Child Health and Public Health, Woman Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. Electronic address: ida.paris@policlinicogemelli.it., Martín M; Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, 28007 Madrid, Spain. Electronic address: mmartin@geicam.org., De Placido S; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy. Electronic address: deplacid@unina.it., Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, 16132 Genova, Italy; Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy. Electronic address: lucia.delmastro@hsanmartino.it., Jerusalem G; Medical Oncology, CHU Sart Tilman Liège and University of Liège, 4000 Liège, Belgium. Electronic address: g.jerusalem@chuliege.be., Curigliano G; Istituto Europeo di Oncologia, IRCCS ed Università di Milano, 20141 Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, 08036 Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain; Department of Medicine, University of Barcelona, 08036 Barcelona, Spain; Oncology Department, IOB Institute of Oncology, Quiron Group, 08023 Barcelona, Spain; SOLTI Cooperative Research Group, 08008 Barcelona, Spain. Electronic address: alprat@clinic.cat., Generali D; Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100 Cremona, Italy. Electronic address: dgenerali@units.it.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2022 Dec; Vol. 111, pp. 102468. Date of Electronic Publication: 2022 Sep 28.
Autor:
Kuemmel S; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany. s.kuemmel@kem-med.com., Campone M; Institut de Cancérologie de l'Ouest-Centre René Gauducheau, St Herblain, France., Loirat D; Medical Oncology Department and D3i, Institut Curie, Paris, France., Lopez RL; Clinical University Hospital & Health Research Institute of Santiago de Compostela-CIBERONC, Santiago de Compostela, Spain., Beck JT; Highlands Oncology Group, Fayetteville, Massachusetts., De Laurentiis M; Istituto Nazionale dei Tumori IRCCS 'Fondazione Pascale', Napoli, Italy., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Kwong A; Queen Mary Hospital, The University of Hong Kong, Hong Kong., Steger GG; Department of Internal Medicine I, Division of Oncology and Gaston H. Glock Research Center, Medical University of Vienna, Vienna, Austria., Adelantado EZ; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Duhoux FP; King Albert II Cancer Institute, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium., Greil R; Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT and Cancer Cluster Salzburg, Salzburg, Austria., Kuter I; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Lu YS; National Taiwan University Hospital, Taipei, Taiwan., Tibau A; Oncology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain., Özgüroğlu M; Istanbul University - Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey., Scholz CW; Vivantes Klinikum Am Urban, Berlin, Germany., Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Vega E; CIOCC-Grupo Hospitalario de Madrid, Madrid, Spain., Wimberger P; Carl Gustav Carus University, TU Dresden, Dresden, Germany., Zamagni C; Osp.di bologna, Bologna, Italy., Couillebault XM; Novartis Pharma AG, Basel, Switzerland., Fan L; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Guerreiro N; Novartis Pharma AG, Basel, Switzerland., Mataraza J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Sand-Dejmek J; Novartis Pharma AG, Basel, Switzerland., Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, Western Australia, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jan 01; Vol. 28 (1), pp. 106-115. Date of Electronic Publication: 2021 Oct 06.
Autor:
Cabel L; Curie, Saint Cloud, France. Electronic address: Luc.cabel@curie.fr., Carton M; Curie, Saint Cloud, France., Pistilli B; Gustave Roussy, Paris, France., Dalenc F; Claudius Regaud IUCT, Toulouse, France., Vanlemnens L; Centre Oscar Lambret, Lille, France., Levy C; Centre Francois Baclesse, Caen, France., Jacot W; ICM, Montpellier, France., Debled M; Institut Bergonie, Bordeaux, France., Loeb A; Centre Henri Becquere, Rouen, France., Hennequin A; Centre Georges-Francois Leclerc, Dijon, France., De la Motte Rouge T; Centre Eugene Marquis, Rennes, France., Laborde L; Institut Paoli-Calmettes, Marseille, France., Laurent C; Institut de Cancérologie Lorraine, Vandoeuvre-les-Nancy, France., Chamorey E; Centre Antoine Lacassagne, Nice, France., Parent D; Institut Jean Godinot, Reims, France., Petit T; Centre Paul Strauss, Strasbourg, France., Mouret-Reynier MA; Centre Jean Perrin, Clermont-Ferrand, France., Campone M; Institut de Cancérologie de L'Ouest, Angers et Nantes, France., Perrocheau G; Institut de Cancérologie de L'Ouest, Angers et Nantes, France., Labreveux C; Unicancer, Paris, France., Bachelot T; Centre Léon Bérard, Lyon, France., Robain M; Unicancer, Paris, France., Lerebours F; Curie, Saint Cloud, France.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2021 Apr; Vol. 56, pp. 18-25. Date of Electronic Publication: 2021 Jan 30.
Autor:
Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Filleron T; Department of Biostatistics, Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France., Bieche I; Department of Genetics, Institut Curie and Paris-Descartes University, Paris, France., Arnedos M; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France., Campone M; Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain et Angers, France., Dalenc F; Department of Medical Oncology, Institut Claudius-Regaud, IUCT Oncopole and University of Paul Sabatier, Toulouse, France., Coussy F; Department of Medical Oncology, Institut Curie, Paris, France., Sablin MP; Department of Medical Oncology, Institut Curie, Paris, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Lefeuvre-Plesse C; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Goncalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Reynier MM; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Jacot W; Department of Medical Oncology, Institut de Cancérologie de Montpellier, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194 and Montpellier Université, Montpellier, France., You B; Department of Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL); Centre d'Investigation de Thérapeutiques en Oncologie et Hématologie de Lyon (CITOHL); Univ Lyon, Université Claude Bernard Lyon 1; EMR UCBL/HCL 3738; GINECO, Lyon, France.; Centre Hospitalier Lyon Sud, Pierre Bénite, France., Barthelemy P; Institut de Cancérologie Strasbourg, Strasbourg, France.; Hôpitaux Universitaire de Strasbourg, Strasbourg, France., Verret B; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France., Isambert N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Tchiknavorian X; Centre Hospitalier Intercommunal Toulon La Seyne-sur-Mer, Hôpital Sainte Musse, Toulon, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Thery JC; Department of Medical Oncology, Centre Henri Becquerel, University of Medicine of Rouen, Rouen, France., L'Haridon T; Centre Hospitalier Départemental de Vendée, La Roche Sur Yon, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France., Mege A; Institut Sainte Catherine, Avignon, France., Del Piano F; Hôpitaux du Leman, Thonon Les Bains, France., Rouleau E; Cancer Genetics Laboratory, Department of Pathology and Medical Biology, Gustave Roussy Cancer Campus, Villejuif, France., Tran-Dien A; INSERM UMR981 and Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris Saclay, Le Kremlin-Bicetre, France., Adam J; Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France.; INSERM U1186, Gustave Roussy Cancer Campus, Villejuif, France., Lusque A; Department of Biostatistics, Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France., Jimenez M; Unicancer, Paris, France., Jacquet A; Unicancer, Paris, France., Garberis I; INSERM UMR981 and Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris Saclay, Le Kremlin-Bicetre, France., Andre F; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France. fabrice.andre@gustaveroussy.fr.; INSERM UMR981 and Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. fabrice.andre@gustaveroussy.fr.; Université Paris Saclay, Le Kremlin-Bicetre, France. fabrice.andre@gustaveroussy.fr.
Publikováno v:
Nature medicine [Nat Med] 2021 Feb; Vol. 27 (2), pp. 250-255. Date of Electronic Publication: 2021 Jan 18.
Autor:
Ben Azzouz F; Unité de Bioinfomique, Institut de Cancérologie de L'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France; SIRIC ILIAD, Nantes, Angers, France., Michel B; Unité de Bioinfomique, Institut de Cancérologie de L'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France; SIRIC ILIAD, Nantes, Angers, France; Ecole Centrale de Nantes, 1 Rue de La Noë, 44300, Nantes, France; Laboratoire de Mathématiques Jean Leray, BP 92208, 2 Rue de La Houssinière, 44322, Nantes Cedex 03, France., Lasla H; Unité de Bioinfomique, Institut de Cancérologie de L'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France; SIRIC ILIAD, Nantes, Angers, France., Gouraud W; Unité de Bioinfomique, Institut de Cancérologie de L'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France; SIRIC ILIAD, Nantes, Angers, France., François AF; Ecole Centrale de Nantes, 1 Rue de La Noë, 44300, Nantes, France., Girka F; Ecole Centrale de Nantes, 1 Rue de La Noë, 44300, Nantes, France., Lecointre T; Ecole Centrale de Nantes, 1 Rue de La Noë, 44300, Nantes, France., Guérin-Charbonnel C; Unité de Bioinfomique, Institut de Cancérologie de L'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France; SIRIC ILIAD, Nantes, Angers, France., Juin PP; SIRIC ILIAD, Nantes, Angers, France; CRCINA, INSERM, CNRS, Université de Nantes, Université D'Angers, Institut de Recherche en Santé-Université de Nantes, 8 Quai Moncousu - BP 70721, 44007, Nantes Cedex 1, France., Campone M; SIRIC ILIAD, Nantes, Angers, France; CRCINA, INSERM, CNRS, Université de Nantes, Université D'Angers, Institut de Recherche en Santé-Université de Nantes, 8 Quai Moncousu - BP 70721, 44007, Nantes Cedex 1, France; Oncologie Médicale, Institut de Cancérologie de L'Ouest - René Gauducheau, Bd Jacques Monod, 44805, Saint Herblain Cedex, France., Jézéquel P; Unité de Bioinfomique, Institut de Cancérologie de L'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France; SIRIC ILIAD, Nantes, Angers, France; CRCINA, INSERM, CNRS, Université de Nantes, Université D'Angers, Institut de Recherche en Santé-Université de Nantes, 8 Quai Moncousu - BP 70721, 44007, Nantes Cedex 1, France. Electronic address: pascal.jezequel@ico.unicancer.fr.
Publikováno v:
Computers in biology and medicine [Comput Biol Med] 2021 Feb; Vol. 129, pp. 104171. Date of Electronic Publication: 2020 Dec 09.
Autor:
Dagher E; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Nantes, France., Simbault L; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Nantes, France., Abadie J; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Nantes, France.; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France., Loussouarn D; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; Anatomie Pathologique, Hôtel-Dieu, CHU de Nantes, Nantes, France., Campone M; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; Integrated Center for Oncology, ICO, Nantes, France., Nguyen F; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Nantes, France.; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; Integrated Center for Oncology, ICO, Nantes, France.
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2020 Jan; Vol. 42 (1), pp. 1010428319901052.
Autor:
Dagher E; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Oniris site Chantrerie, CS40706, 44307, Cedex 3, Nantes, France., Royer V; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Oniris site Chantrerie, CS40706, 44307, Cedex 3, Nantes, France., Buchet P; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Oniris site Chantrerie, CS40706, 44307, Cedex 3, Nantes, France., Abadie J; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Oniris site Chantrerie, CS40706, 44307, Cedex 3, Nantes, France.; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France., Loussouarn D; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; Hôtel-Dieu CHU de Nantes, Anatomie Pathologique, cedex 01, 44093, Nantes, France., Campone M; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.; Integrated Center for Oncology, ICO, 15 rue André Boquel, cedex 02, 49055, Angers, France., Nguyen F; AMaROC, Oniris (Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering), Oniris site Chantrerie, CS40706, 44307, Cedex 3, Nantes, France. frederique.nguyen@oniris-nantes.fr.; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France. frederique.nguyen@oniris-nantes.fr.; Integrated Center for Oncology, ICO, 15 rue André Boquel, cedex 02, 49055, Angers, France. frederique.nguyen@oniris-nantes.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Dec 30; Vol. 19 (1), pp. 1267. Date of Electronic Publication: 2019 Dec 30.
Autor:
Darlix A; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), University of Montpellier, 208 Rue des Apothicaires, 34298, Montpellier, France. amelie.darlix@icm.unicancer.fr., Louvel G; Department of Radiation Therapy, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France., Fraisse J; Biometrics Unit, Institut du Cancer de Montpellier (ICM), University of Montpellier, 208 Rue des Apothicaires, 34298, Montpellier, France., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), University of Montpellier, 208 Rue des Apothicaires, 34298, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut du Cancer de Montpellier, University of Montpellier 208 Rue des Apothicaires, 34298, Montpellier, France., Brain E; Department of Medical Oncology, Institut Curie, 26 Rue d'Ulm, 75005, Paris & Saint-Cloud, France., Debled M; Department of Medical Oncology, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011, Clermont Ferrand, France., Goncalves A; Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009, Marseille, France., Dalenc F; Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059, Toulouse, France., Delaloge S; Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard-Vaillant, 94800, Villejuif, France., Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Centre René Gauducheau, Boulevard Jacques Monod, 44805, Saint Herblain, France., Augereau P; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, 15 rue André Boquel, 49055, Angers, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de valambrose, 06189, Nice, France., Levy C; Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000, Caen, France., Fumet JD; Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079, Dijon, France., Lecouillard I; Department of Radiation Oncology, Centre Eugène Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000, Rennes, France., Cottu P; Department of Medical Oncology, Institut Curie, 26 Rue d'Ulm, 75005, Paris & Saint-Cloud, France., Petit T; Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000, Strasbourg, France., Uwer L; Medical Oncology Department, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519, Vandœuvre-lès-Nancy, France., Jouannaud C; Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100, Reims, France., Leheurteur M; Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France., Dieras V; Department of Radiation Oncology, Centre Eugène Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000, Rennes, France., Robain M; Department of Research and Development, Unicancer, 101 Rue de Tolbiac, 75654, Paris, France., Chevrot M; Department of Research and Development, Unicancer, 101 Rue de Tolbiac, 75654, Paris, France., Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008, Lyon, France.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Dec; Vol. 121 (12), pp. 991-1000. Date of Electronic Publication: 2019 Nov 13.
Autor:
Jézéquel P; Unité de Bioinfomique, Institut de Cancérologie de l'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - René Gauducheau, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; INSERM U1232, 44007, Nantes Cedex, France.; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France., Guette C; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France.; Institut de Cancérologie de l'Ouest-Paul Papin, 49055, Angers Cedex, France., Lasla H; Unité de Bioinfomique, Institut de Cancérologie de l'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France., Gouraud W; Unité de Bioinfomique, Institut de Cancérologie de l'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - René Gauducheau, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France., Boissard A; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France.; Institut de Cancérologie de l'Ouest-Paul Papin, 49055, Angers Cedex, France., Guérin-Charbonnel C; Unité de Bioinfomique, Institut de Cancérologie de l'Ouest, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; Unité Mixte de Génomique du Cancer, Institut de Cancérologie de l'Ouest - René Gauducheau, Bd Jacques Monod, 44805, Saint Herblain Cedex, France.; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France., Campone M; INSERM U1232, 44007, Nantes Cedex, France.; SIRIC ILIAD, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France.; Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, 44805, Saint Herblain Cedex, France.
Publikováno v:
Proteomics [Proteomics] 2019 Nov; Vol. 19 (21-22), pp. e1800484. Date of Electronic Publication: 2019 May 07.